M-FORCE 6评分:预测脑膜瘤切除术后6周功能独立性的工具
本研究回顾性分析592例颅内脑膜瘤切除术患者(2009-2024年),主要终点为术后6周功能依赖(mRS≥3)。通过多因素logistic回归确定独立预测因子并构建M-FORCE 6评分,将患者分为四组风险,模型AUC为0.76,校准良好,需外部验证。
要点
- M-FORCE 6评分纳入颅底起源、幕下位置、术前依赖、肿瘤≥40mm和合并症负担。
- 评分将患者分为低(0-3分,6.2%)、中(4-6分,26.5%)、高(7-9分,46.9%)、极高(10-13分,71.4%)风险组。
- 模型和评分的乐观校正AUC均为0.76,校准良好,决策曲线显示净获益。
核心结论
- M-FORCE 6评分是一种透明、脑膜瘤特异性的术前风险分层工具,整合人口学、临床和影像学特征,需外部验证。
研究设计与样本
- 回顾性分析单中心592例颅内脑膜瘤切除术患者(2009-2024年),使用多因素logistic回归筛选预测因子并构建评分,采用10000次bootstrap重采样进行内部验证。
主要发现
- 颅底起源(OR 2.21)、幕下位置(OR 2.12)、术前依赖(mRS>2,OR 2.27)、肿瘤大小≥40 mm(OR 3.06)、合并症负担(CCI>2,OR 2.41;CCI>6,OR 2.46)独立预测6周功能依赖。
- 低风险组(0-3分)6周功能依赖风险为6.2%,中风险组(4-6分)为26.5%,高风险组(7-9分)为46.9%,极高风险组(10-13分)为71.4%。
- 多因素模型和评分的乐观校正AUC均为0.76,校准良好,决策曲线分析显示有利净获益。
关键数值与推荐
- M-FORCE 6评分总分0-13分,风险分组:低0-3分,中4-6分,高7-9分,极高10-13分。
- 6周功能依赖定义为mRS评分≥3。
临床怎么用
- 可用于脑膜瘤患者术前风险分层和咨询,帮助识别高风险患者并指导临床决策。
局限性
- 回顾性单中心设计,需外部验证确认普适性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Accurate prognostic assessment is crucial for guiding clinical decisions in meningioma patients. Traditional prognostic indexes have been limited by subjectivity, oversimplification, or lack of specific validation for meningiomas, leading to inaccuracies from misaligned scaling objectives. This study aimed to create a refined weighting system, integrating variables from prior indexes to better reflect prognostic significance in meningioma patients. METHODS: The authors retrospectively analyzed the data of 592 patients who underwent intracranial meningioma resection at a single institution (2009-2024). The primary endpoint was lack of functional independence at 6 weeks (modified Rankin Scale [mRS] score ≥ 3). Univariable screening and multivariable logistic regression identified independent predictors, which were translated into a simplified point-based system: Meningioma Functional Outcome Risk and Counseling Estimator (M-FORCE) 6 score. Internal validation was performed using 10,000 bootstrap resamples. Discrimination, calibration, and clinical utility (decision curve analysis) were assessed. RESULTS: Skull base origin (OR 2.21), infratentorial location (OR 2.12), preoperative dependence (mRS score > 2, OR 2.27), tumor size ≥ 40 mm (OR 3.06), and comorbidity burden (Charlson Comorbidity Index [CCI] score > 2, OR 2.41; CCI score > 6, OR 2.46) independently predicted functional dependence at 6 weeks. These variables were incorporated into the M-FORCE 6 score. Patients were stratified into four risk groups: low (0-3 points, 6.2% risk), intermediate (4-6 points, 26.5% risk), high (7-9 points, 46.9% risk), and very high (10-13 points, 71.4% risk). The optimism-corrected areas under the curve of the multivariable model and the score were both 0.76, with excellent calibration and favorable net benefit on decision curve analysis. CONCLUSIONS: The M-FORCE 6 score provides a transparent, meningioma-specific tool for preoperative risk stratification, integrating demographic, clinical, and radiological features into a simple and reproducible model. External validation is warranted to confirm its generalizability.
引用
- Martinez-Perez R, Cepeda S, Ahmad M, et al. Development and internal validation of the Meningioma Functional Outcome Risk and Counseling Estimator 6 score, a point-based prognostic tool for predicting 6-week functional independence after intracranial meningioma resection. J Neurosurg. 2026. PMID: 42398113. doi:10.3171/2026.1.JNS252588
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。